NYSE · Analyst Forecast

AstraZeneca PLC (AZN) Stock Forecast & Price Target

$182.23 NYSE: AZN Market Cap $282.62B

Price as of Nov 17, 2026 (intraday, delayed) · Analyst estimates retrieved Nov 12, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering AstraZeneca PLC (AZN), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For AstraZeneca PLC, analysts forecast revenue rising from $58.65B in 2025 to $81.48B in 2030; the average estimate for 2030 earnings per share is $15.98; with published estimates ranging from $15.27 to $16.40; 23 analysts contribute to these figures. These are forecasts published by analysts, not results.

Analyst price targets

MeasureValue
Current priceWhat the share trades at now.$182.23
Consensus targetThe average of the price targets analysts have published.$211.00
Median targetThe middle target, less affected by a single outlier.$211.00
Highest targetThe most optimistic published target.$216.00
Lowest targetThe most pessimistic published target.$206.00
Difference from priceHow far the consensus target sits from today’s price.+15.8%

A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.

Revenue forecast (USD)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2025$57.37B$58.65B$59.41B15
2026$61.50B$62.71B$63.14B18
2027$63.73B$66.79B$67.82B18
2028$66.74B$70.87B$74.23B23
2029$73.76B$76.34B$77.92B11
2030$78.72B$81.48B$83.17B11

Earnings per share forecast

YearLowAverageHighAnalysts
2025$8.83$9.16$9.4215
2026$10.09$10.26$10.3618
2027$11.11$11.35$11.8118
2028$10.10$12.60$14.3623
2029$13.77$14.40$14.7911
2030$15.27$15.98$16.4011

AstraZeneca PLC (AZN) forecast — frequently asked questions

What is the analyst price target for AstraZeneca PLC?

Analysts covering AstraZeneca PLC (AZN) have a consensus price target of $211.00, 15.8% above the current price of $182.23. Published targets range from $206.00 to $216.00. A price target is a forecast, not a measure of value, and targets are revised often.

What are analysts forecasting for AstraZeneca PLC's earnings?

The average analyst estimate for AstraZeneca PLC (AZN) earnings per share in 2030 is 15.98, with individual estimates between 15.27 and 16.40.

How much revenue is AstraZeneca PLC expected to make?

Analysts forecast AstraZeneca PLC (AZN) revenue of $81.48B in 2030, based on 11 published estimates.

How many analysts cover AZN?

23 analysts contribute estimates for AstraZeneca PLC (AZN). Thin coverage makes an average less reliable.

Analyst forecasts for other Drug Manufacturers - General stocks

LLY forecastJNJ forecastABBV forecastMRK forecastNVS forecastAMGN forecastGILD forecastNVO forecastPFE forecastBMY forecastAll Drug Manufacturers - General stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNYSE High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.